Response to Yang, Shi, Wang et al
- PMID: 31424546
- PMCID: PMC7156932
- DOI: 10.1093/jnci/djz163
Response to Yang, Shi, Wang et al
Comment on
-
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. doi: 10.1093/jnci/djy148. J Natl Cancer Inst. 2018. PMID: 30380096
-
RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis.J Natl Cancer Inst. 2020 Apr 1;112(4):426-427. doi: 10.1093/jnci/djz162. J Natl Cancer Inst. 2020. PMID: 31424539 Free PMC article. No abstract available.
References
-
- Oh M, McBride A, Yun S, et al. Reply to Katona et al. J Natl Cancer Inst. 2019;111(5):524–525. - PubMed
-
- Ford D, Easton DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994;343(8899):692–695. - PubMed
-
- Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310–1316. - PubMed
-
- Evans DG, Clancy T, Hill J, Tischkowitz M.. Is there really an increased risk of early colorectal cancer in women with BRCA1 pathogenic mutations? Clin Genet. 2016;89(3):399.. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
